Richard Henry Parrish

Prof. Dr. Richard Henry Parrish

Mercer University, Macon, Georgia, USA
+1
orcid
Alice L. WaltonSchool of Medicine

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2024 in World Journal of Surgery
Verified
Journal Article
Closed access
BPBowen K. Powers
Bowen K. Powers
HPHarley L. Ponder
Harley L. Ponder
RFRachelle Findley
Rachelle Findley
RWRachel Wolfe
Rachel Wolfe
GPGourang P. Patel
Gourang P. Patel
FCfor the Enhanced Recovery Comparative Pharmacotherapy Collaborative
for the Enhanced Recovery Comparative Pharmacotherapy Collaborative

1 March 2019 in International Journal of Surgery
Verified
Journal Article
Closed access
JLJenna Lovely
Jenna Lovely
SHSara J. Hyland
Sara J. Hyland
ASApril N. Smith
April N. Smith
GNGregg Nelson
Gregg Nelson
OLOlle Ljungqvist
Olle Ljungqvist
Richard Henry ParrishRichard Henry Parrish
Richard Henry Parrish
One of the most durable approaches to perioperative enhanced recovery programming has culminated in the formation of perioperative organizations devoted to improvements in the quality of the surgical patient experience, such as the Enhanced Recovery After Surgery (ERAS®) Society. Members of the American College of Clinical Pharmacy (ACCP) Perioperative Care Practice and Research Network (PRN) and officials from the ERAS® Society present an opinion that: (1) identifies therapeutic options within each pharmacotherapy-intensive area of ERAS®; (2) generates applied research questions that would allow for comparative analyses of pharmacotherapy options within ERAS® programs; (3) proposes collaborative practice opportunities between key stakeholders in the surgical journey and clinical pharmacists to manage drug therapy problems and research questions; and (4) highlights examples of pharmacist-led cost savings attributed to ERAS® implementation. Clinical pharmacists, working in this manner with the perioperative team across the care continuum, have optimized pharmacotherapy towards measurable outcomes improvements, and stand ready to partner with inter-professional stakeholders and organizations to advance the care of our mutual patients.

5 February 2013 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
VBVarsha Bhatt‐Mehta
Varsha Bhatt‐Mehta
MBMarcia L. Buck
Marcia L. Buck
ACAllison Chung
Allison Chung
EFElizabeth A. Farrington
Elizabeth A. Farrington
THTracy M. Hagemann
Tracy M. Hagemann
Richard Henry ParrishRichard Henry Parrish
Richard Henry Parrish

21 October 2019 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
GPGourang P. Patel
Gourang P. Patel
SHSara J. Hyland
Sara J. Hyland
KBKara L. Birrer
Kara L. Birrer
RWRachel C. Wolfe
Rachel C. Wolfe
JLJenna K. Lovely
Jenna K. Lovely
Richard Henry ParrishRichard Henry Parrish
Richard Henry Parrish
Current published guidelines for perioperative pharmacy services have limited information on the development and implementation of a robust clinical pharmacy program across the surgical continuum of care. This publication defines the responsibilities and scope of practice of the Perioperative Clinical Pharmacist (PCPh), supporting the PCPh as a critical member of the interprofessional surgical patient care team. Opportunities for pharmacist role integration into perioperative medication management processes are described along with published examples of successful PCPh practice models, including those with interventions targeted toward Enhanced Recovery Pathways (ERP). Recommended training and competencies for future and practicing perioperative pharmacists, in addition to considerations for precepting and scholarly activities, are also outlined. Finally, future developments in perioperative pharmacy practice are discussed, including technological advancements, improved predictive models, and expansion of collaborative practice agreements.

1 November 2006 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
Richard Henry ParrishRichard Henry Parrish
Richard Henry Parrish
DPDanielle E. Pazdur
Danielle E. Pazdur
POPhilip J. O'DOnnell
Philip J. O'DOnnell

1 December 2012 in The Journal of Pediatric Pharmacology and Therapeutics
Verified
Journal Article
Closed access
VBVarsha Bhatt-Mehta
Varsha Bhatt-Mehta
MBMarcia L. Buck
Marcia L. Buck
ACAllison M. Chung
Allison M. Chung
EFElizabeth Anne Farrington
Elizabeth Anne Farrington
THTracy M. Hagemann
Tracy M. Hagemann
Richard Henry ParrishRichard Henry Parrish
Richard Henry Parrish
Children warrant access to care from clinical pharmacists trained in pediatrics. The American College of Clinical Pharmacy Pediatrics Practice and Research Network (ACCP Pediatrics PRN) released an opinion paper in 2005 with recommendations for improving the quality and quantity of pediatric pharmacy education in colleges of pharmacy, residency programs, and fellowships. While progress has been made in increasing the availability of pediatric residencies, there is still much to be done to meet the direct care needs of pediatric patients. The purpose of this Joint Opinion paper is to outline strategies and recommendations for expanding the quality and capacity of pediatric clinical pharmacy practitioners by 1) elevating the minimum expectations for pharmacists entering practice to provide pediatric care; 2) standardizing pediatric pharmacy education; 3) expanding the current number of pediatric clinical pharmacists; and 4) creating an infrastructure for development of pediatric clinical pharmacists and clinical scientists. These recommendations may be used to provide both a conceptual framework and action items for schools of pharmacy, health care systems, and policymakers to work together to increase the quality and quantity of pediatric training, practice, or research initiatives.